Abstract
Ascorbate and complexes of Cu(II) and Fe(III) are capable of generating significant levels of oxygen free radicals. Exposure of erythrocytes to such oxidative stress leads to increased levels of methemoglobin and extensive changes in cell morphology. Cu(II) per mole is much more effective than Fe(III). However, isolated hemoglobin is oxidized more rapidly and completely by Fe(III)- than by Cu(II)-complexes. Both Fe(III) and Cu(II) are capable of inhibiting a number of the key enzymes of erythrocyte metabolism. The mechanism for the enhanced activity of Cu(II) has not been previously established. Using intact erythrocytes and hemolysates we demonstrate that Cu(II)-, but not Fe(III)-complexes in the presence of ascorbate block NADH-methemoglobin reductase. Complexes of Cu(II) alone are not inhibitory. The relative inability of Fe(III)-complexes and ascorbate to cause methemoglobin accumulation is not owing to Fe(III) association with the membrane, or its failure to enter the erythrocytes. The toxicity of Cu(II) and ascorbate appears to be a result of site-specific oxidative damage of erythrocyte NADH-methemoglobin reductase and the enzyme's subsequent inability to reduce the oxidized hemoglobin.
Similar content being viewed by others
References
B. Halliwell, and J. M. C. Gutteridge, Role of free radicals and catalytic metal ions in human disease: an overview,Methods Enzymol. 186, 1–85 (1990).
W. Pryor, Free radical biology: Xenobiotics, cancer, and aging,Ann. NY Acad. Sci. 393, 1–22 (1982).
P. Saltman, Oxidative stress: a radical view,Semin. Hematol. 26, 249–256 (1989).
M. Chevion, A site-specific mechanism for free radical induced biological damage: the essential role of redox-active transition metals,Free Rad. Biol. Med. 5, 27–37 (1988).
E. Shinar, T. Navok, and M. Chevion, The analogous mechanisms of enzymatic inactivation induced by ascorbate and superoxide in the presence of copper,J. Biol. Chem. 258, 14,778–14,783 (1983).
E. R. Stadtman, Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences,Free Rad. Biol. Med. 9, 315–325 (1990).
B. van Dyke, D. A. Clopton, and P. Saltman, Buffer-induced anomalies in the Fenton chemistry of iron and copper,Inorg. Chim. Acta 242–243, 1–5 (1996).
R. L. Levine, Oxidative modification of glutamine synthetase. I. Inactivation is due to loss of one histidine residue.J. Biol. Chem. 258, 11,823–11,827 (1983).
R. L. Levine, Oxidative modification of glutamin synthetase. II. Characterization of the ascorbate model system,J. Biol. Chem. 258, 11,828–11,833 (1983).
G. Marx, and M. Chevion, Site specific modification of albumin by free radicals. Reaction of copper(II) and ascorbate.Biochem. J. 236, 397–400 (1986).
J. Masuoka, and P. Saltman, Zinc(II) and copper(II) binding to serum albumin. A comparative study of dog, bovine, and human albumin,J. Biol. Chem. 269, 25,557–25,561 (1994).
E. A. Rachmilewitz, E. Shinar, O. Shalev, U. Galilli, and S. L. Schrier, Erythrocyte membrane alterations in beta-thalassemia,Clin. Haematol. 14, 163–182 (1985).
E. Shinar, O. Shalev, E. A. Rachmilewitz, and S. L. Schrier, Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia,Blood 70, 158–164 (1987).
R. P. Hebbel, Autooxidation and a membrane-associated “Fenton reagent” a possible explanation for development of membrane lesions in sickle erythrocytes,Clin. Haematol. 14, 129–140 (1985).
R. P. Hebbel, and J. W. Eaton, Pathobiology of heme interaction with the erythrocyte membrane,Semin. Hematol. 26., 136–149 (1989).
R. P. Hebbel, W. T. Morgan, J. W. Eaton, and B. E. Hedlund, Accelerated autoxidation and heme loss due to instability of sickle hemoglobin,Proc. Natl. Acad. Sci. USA 85, 237–241 (1988).
T. Repka, O. Shalev, R. Reddy, J. Yuan, A. Abrahamov, E. A. Rachmilewitz, P. S. Low, and R. P. Hebbel, Non-random association of free iron with membranes of sickle and beta-thalassemic erythrocytes.Blood 82, 3204–3210 (1993).
M. M. Kay, G. J. Bosman, S. S. Shapiro, A. Bendich, and P. S. Bassel, Oxidation as a possible mechanism of cellular aging: Vitamin E deficiency causes premature aging and IgG binding to erythrocytes,Proc. Natl. Acad. Sci. USA 83, 2463–2467 (1986).
M. M. Kay, T. Wyant, and J. Goodman, Autoantibodies to band 3 during aging and disease and aging interventions,Ann. NY Acad. Sci. 719, 419–447 (1994).
S. K. Jain, Evidence for membrane lipid peroxidation during thein vivo aging of human erythrocytes,Biochim. Biophys. Acta 937, 205–210 (1988).
P. S. Low and R. Kannan, Effect of hemoglobin denaturation on membrane structure and IgG binding role in red cell aging.Prog. Clin. Biol. Res. 319, 525–546 (1989).
E. Shinar, E. A. Rachmilewitz, A. Shifter, E. Rahamin, and P. Saltman, Oxidative damage to human red cells induced by copper and iron complexes in the presence of ascorbate,Biochim. Biophys. Acta 1014, 66–72 (1989).
L. A. Eguchi, and P. Saltman, Kinetics and mechanisms of metal reduction by hemoglobin 1. Reduction of iron (III) complexes,Inorg. Chem. 26, 3665–3669 (1987).
L. A. Eguchi, and P. Saltman, Kinetics and mechanisms of metal reduction by hemoglobin. 2. Reduction of copper(II) complexes,Inorg. Chem. 26, 3669–3672 (1987).
C. C. Winterbourn, and R. W. Carrell, Oxidation of human haemoglobin by copper. Mechanism and suggested role of the thiol group of residue β-93.Biochem. J. 165, 141–148 (1977).
A. Mansouri, and A. A. Lurie, Concise review: methemoglobinemia,Am. J. Hematol. 42, 7–12 (1993).
C. R. Zerez, N. A. Lachant, and K. R. Tanaka, Impaired erythrocyte methemoglobin reduction in sickle cell disease: dependence of methemoglobin reduction on reduced nicotinamide adenine dinucleotide content,Blood 76, 1008–1014 (1990).
M. Boulard, K.-G. Blume, and E. Beutler, The effect of copper on red cell enzyme activities,J. Clin. Invest. 51, 459–461 (1972).
S. J. Forman, K. S. Kumar, A. G. Redeker, and P. Hochstein, Hemolytic anemia in Wilson disease: clinical findings and biochemical methods,Am. J. Hematol. 9, 269–275 (1980).
E. Baysal, and C. A. Rice-Evans, Modulation of iron-mediated oxidant damage in erythrocytes by cellular energy levels,Free Rad. Res. Commun. 3, 227–232 (1987).
A. Deiss, G. R. Lee, and G. E. Cartwright, hemolytic anemia in Wilson's disease,Ann. Intern. Med. 73, 413–418 (1970).
J. P. Flikweert, R. K. J. Hoorn, and G. E. J. Staal, The effect of copper on human erythrocyte glutathione reductase,Int. J. Biochem. 5, 649–653 (1974).
N. Shaklai, V. S. Sharma, and H. M. Ranney, Interaction of sickle cell hemoglobin with erythrocyte membranes.Proc. Natl. Acad. Sci. USA 78, 65–68 (1981).
E. Baysal, S. G. Sullivan, and A. Stern, Binding of iron to human red cell membranes,Free Rad. Res. Commun. 8, 55–59 (1989).
C. N. Oliver, B-W. Ahn, E. J. Moreman, S. Goldstein, and E. R. Stadtman, Age-related changes in oxidized proteins,J. Biol. Chem. 262, 5488–5491 (1987).
D. R. Thorburn, and E. Beutler, Decay of hexokinase during reticulocyte maturation is oxidative damage a signal for destruction?,Biochem. Biophys. Res. Commun. 162, 612–618 (1989).
V. Stocchi, B. Biagiarelli, M. Fiorani, F. Palma, G. Piccoli, L. Cucchiarini, and M. Dacha, Inactivation of rabbit red blood cell hexokinase activity promotedin vitro by an oxygen-radical- generating system,Arch. Biochem. Biophys. 311, 160–167 (1994).
L. Fucci, C. N. Oliver, M. J. Coon, and E. R. Stadtman, Inactivation of key metabolic enzymes by mixed-function oxidation reactions: possible implication in protein turnover and ageing,Proc. Natl. Sci. USA 80, 1521–1525 (1983).
J. Masuoka, J. Hegenauer, B. R. van Dyke, and P. Saltman, Intrinsic stochiometric equilibrium constants for the binding of zinc(II) and copper(II) to the high affinity site of serum albumin.J. Biol. Chem. 268, 21,533–21,537 (1993).
T. G. Spiro, and P. Saltman, Polynuclear complexes of iron and their biological implications, inStructure and Bonding, vol. 6, P. Hemmerich, C. K. Jorgensen, J. B. Neilands, R. S. Nyholm, D. Reinen, and R. J. P. Williams, eds., Springer-Verlag, New York, pp. 117–156 (1969).
E. Beutler, The preparation of red cells for assay, inRed Cell Metabolism. A Manual of Biochemical Techniques, 3rd ed, Grune & Stratton, Orlando, pp. 8–18 (1984).
E. J. Van Kampen and W. G. Zijlstra, Determination of hemoglobin and its derivatives.Adv. Clin. Chem. 8, 141–187 (1965).
C. C. Winterbourn, Oxidative reactions of hemoglobin,Methods Enzymol. 186, 265–272 (1990).
E. Hegesh, N. Gruener, S. Cohen, R. Bochkovsky, and H. I. Shuval, A sensitive micromethod for the determination of methemoglobin in blood,Clin. Chim. Acta 30, 679–682, (1970).
E. Beutler, NADH methemoglobin reductase (NADH-ferricyanide reductase), inRed Cell Metabolism. A Manual of Biochemical Techniques, 3rd ed., Grune & Stratton, Orlando, pp. 82–83 (1984).
P. G. Passon and D. E. Hultquist, Soluble cytochromeb 5 reductase from human erythrocytes,Biochim. Biophys. Acta 275, 62–73 (1972).
D. Gelvan and P. Saltman, Different cellular targets for Cu- and Fe-catalyzed oxidation observed using a Cu-compatible thiobarbituric acid assay.Biochim. Biophys. Acta 1035, 353–360 (1990).
C. A. Rice-Evans, and E. Baysal, Iron-mediated oxidative stress in erythrocytes,Biochem. J. 244, 191–196 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clopton, D.A., Saltman, P. Copper-specific damage in human erythrocytes exposed to oxidative stress. Biol Trace Elem Res 56, 231–240 (1997). https://doi.org/10.1007/BF02785396
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02785396